1Hiramatsu M,Kubota J,Akizawa T,Koshikawa S,the KRN321 Study Group. Intravenous administration of KRN321(darbepoetin alfa) once every 4 weeks improves and maintains haemoglobin concentrations in peritoneal dialysis patients[A].Istanbul,Turkey,2005.
2Schwartzberg LS,Yee LK,Senecal FM. A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast,lung,or gynecologic cancer[J].Oncologist(The),2004.696-707.
